|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
1997-3-20
|
|
pubmed:abstractText |
To compare the antihypertensive efficacy and systemic tolerability of valsartan, a new angiotensin II receptor antagonist, with placebo and with an angiotensin converting enzyme (ACE) inhibitor, enalapril.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0263-6352
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1147-51
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8986917-Adult,
pubmed-meshheading:8986917-Age Factors,
pubmed-meshheading:8986917-Aged,
pubmed-meshheading:8986917-Angiotensin II,
pubmed-meshheading:8986917-Antihypertensive Agents,
pubmed-meshheading:8986917-Double-Blind Method,
pubmed-meshheading:8986917-Enalapril,
pubmed-meshheading:8986917-Female,
pubmed-meshheading:8986917-Humans,
pubmed-meshheading:8986917-Hypertension,
pubmed-meshheading:8986917-Male,
pubmed-meshheading:8986917-Middle Aged,
pubmed-meshheading:8986917-Tetrazoles,
pubmed-meshheading:8986917-Valine
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalapril.
|
|
pubmed:affiliation |
St Elizabeth Hospital, Tilburg, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
